Annual FCF
-$109.98 M
+$14.33 M+11.53%
December 31, 2023
Summary
- As of February 12, 2025, SYRS annual free cash flow is -$109.98 million, with the most recent change of +$14.33 million (+11.53%) on December 31, 2023.
- During the last 3 years, SYRS annual FCF has fallen by -$49.28 million (-81.18%).
- SYRS annual FCF is now -803.69% below its all-time high of -$12.17 million, reached on December 31, 2014.
Performance
SYRS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$20.69 M
+$8.98 M+30.26%
September 30, 2024
Summary
- As of February 12, 2025, SYRS quarterly free cash flow is -$20.69 million, with the most recent change of +$8.98 million (+30.26%) on September 30, 2024.
- Over the past year, SYRS quarterly FCF has increased by +$11.17 million (+35.06%).
- SYRS quarterly FCF is now -1233.91% below its all-time high of -$1.55 million, reached on March 31, 2020.
Performance
SYRS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$100.05 M
+$11.17 M+10.04%
September 30, 2024
Summary
- As of February 12, 2025, SYRS TTM free cash flow is -$100.05 million, with the most recent change of +$11.17 million (+10.04%) on September 30, 2024.
- Over the past year, SYRS TTM FCF has increased by +$23.08 million (+18.75%).
- SYRS TTM FCF is now -2862.81% below its all-time high of -$3.38 million, reached on March 31, 2015.
Performance
SYRS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SYRS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | +35.1% | +18.8% |
| 3 y3 years | -81.2% | +44.3% | +23.8% |
| 5 y5 years | -163.7% | +44.3% | +23.8% |
SYRS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.1% | +11.5% | -11.2% | +44.3% | at high | +23.8% |
| 5 y | 5-year | -81.2% | +11.5% | -1233.9% | +44.3% | -110.5% | +23.8% |
| alltime | all time | -803.7% | +11.5% | -1233.9% | +44.3% | -2862.8% | +23.8% |
Syros Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$20.69 M(-30.3%) | -$100.05 M(-10.0%) |
| Jun 2024 | - | -$29.67 M(-4.6%) | -$111.22 M(+7.0%) |
| Mar 2024 | - | -$31.10 M(+67.2%) | -$103.94 M(-5.5%) |
| Dec 2023 | -$109.98 M(-11.5%) | -$18.60 M(-41.6%) | -$109.98 M(-10.7%) |
| Sep 2023 | - | -$31.86 M(+42.3%) | -$123.14 M(-3.3%) |
| Jun 2023 | - | -$22.39 M(-39.7%) | -$127.39 M(-3.0%) |
| Mar 2023 | - | -$37.14 M(+16.9%) | -$131.30 M(+5.6%) |
| Dec 2022 | -$124.31 M(+23.3%) | -$31.76 M(-12.1%) | -$124.31 M(+7.4%) |
| Sep 2022 | - | -$36.12 M(+37.4%) | -$115.76 M(+7.1%) |
| Jun 2022 | - | -$26.29 M(-12.8%) | -$108.08 M(-0.5%) |
| Mar 2022 | - | -$30.14 M(+29.9%) | -$108.68 M(+7.8%) |
| Dec 2021 | -$100.78 M(+66.0%) | -$23.21 M(-18.4%) | -$100.78 M(-6.3%) |
| Sep 2021 | - | -$28.44 M(+5.8%) | -$107.52 M(+13.3%) |
| Jun 2021 | - | -$26.88 M(+20.8%) | -$94.86 M(+16.5%) |
| Mar 2021 | - | -$22.25 M(-25.7%) | -$81.40 M(+34.1%) |
| Dec 2020 | -$60.70 M(-16.7%) | -$29.95 M(+89.9%) | -$60.70 M(+22.6%) |
| Sep 2020 | - | -$15.78 M(+17.6%) | -$49.51 M(+4.2%) |
| Jun 2020 | - | -$13.42 M(+765.2%) | -$47.52 M(-11.2%) |
| Mar 2020 | - | -$1.55 M(-91.7%) | -$53.52 M(-26.6%) |
| Dec 2019 | -$72.89 M | -$18.76 M(+36.0%) | -$72.89 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$13.79 M(-29.0%) | -$68.14 M(+4.2%) |
| Jun 2019 | - | -$19.42 M(-7.2%) | -$65.39 M(+8.9%) |
| Mar 2019 | - | -$20.92 M(+49.3%) | -$60.06 M(+44.0%) |
| Dec 2018 | -$41.70 M(-8.5%) | -$14.01 M(+26.8%) | -$41.70 M(+8.8%) |
| Sep 2018 | - | -$11.05 M(-21.6%) | -$38.33 M(+4.0%) |
| Jun 2018 | - | -$14.09 M(+452.3%) | -$36.86 M(+5.7%) |
| Mar 2018 | - | -$2.55 M(-76.0%) | -$34.89 M(-23.4%) |
| Dec 2017 | -$45.55 M(+6.3%) | -$10.63 M(+11.0%) | -$45.55 M(+1.6%) |
| Sep 2017 | - | -$9.58 M(-21.0%) | -$44.83 M(+0.5%) |
| Jun 2017 | - | -$12.12 M(-8.3%) | -$44.60 M(+1.5%) |
| Mar 2017 | - | -$13.22 M(+33.4%) | -$43.93 M(+2.5%) |
| Dec 2016 | -$42.86 M(+77.1%) | -$9.91 M(+6.0%) | -$42.86 M(+3.4%) |
| Sep 2016 | - | -$9.35 M(-18.3%) | -$41.44 M(+8.3%) |
| Jun 2016 | - | -$11.45 M(-5.7%) | -$38.27 M(+16.1%) |
| Mar 2016 | - | -$12.14 M(+43.0%) | -$32.97 M(+36.2%) |
| Dec 2015 | -$24.21 M(+98.9%) | -$8.49 M(+37.5%) | -$24.21 M(+54.1%) |
| Sep 2015 | - | -$6.18 M(+0.3%) | -$15.71 M(+64.8%) |
| Jun 2015 | - | -$6.16 M(+82.4%) | -$9.54 M(+182.4%) |
| Mar 2015 | - | -$3.38 M | -$3.38 M |
| Dec 2014 | -$12.17 M | - | - |
FAQ
- What is Syros Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals annual FCF year-on-year change?
- What is Syros Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals quarterly FCF year-on-year change?
- What is Syros Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Syros Pharmaceuticals?
- What is Syros Pharmaceuticals TTM FCF year-on-year change?
What is Syros Pharmaceuticals annual free cash flow?
The current annual FCF of SYRS is -$109.98 M
What is the all time high annual FCF for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high annual free cash flow is -$12.17 M
What is Syros Pharmaceuticals annual FCF year-on-year change?
Over the past year, SYRS annual free cash flow has changed by +$14.33 M (+11.53%)
What is Syros Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of SYRS is -$20.69 M
What is the all time high quarterly FCF for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high quarterly free cash flow is -$1.55 M
What is Syros Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, SYRS quarterly free cash flow has changed by +$11.17 M (+35.06%)
What is Syros Pharmaceuticals TTM free cash flow?
The current TTM FCF of SYRS is -$100.05 M
What is the all time high TTM FCF for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high TTM free cash flow is -$3.38 M
What is Syros Pharmaceuticals TTM FCF year-on-year change?
Over the past year, SYRS TTM free cash flow has changed by +$23.08 M (+18.75%)